Cancer Incidence Among Persons with Fragile X Syndrome in Finland: a Population-based Study
Overview
Affiliations
Background: Fragile X syndrome is a common inheritable cause of intellectual disability (ID) and is characterised by a large number of CGG repeats at the gene FMR1 located on the X-chromosome. It has been reported that this genetic mechanism may protect against malignant transformations.
Methods: We extracted from the Finnish registry on persons with ID a cohort of 302 persons with a fragile X diagnosis during 1982-1986. Follow-up for cancer incidence was performed in the Finnish Cancer Registry until the end of the year 2005.
Results: There were 11 reported cancers during the mean follow-up of 21.4 years per person. The expected number of cancers based on the average Finnish population was 13.8 and no statistically significant protective effect was detected [standardised incidence ratios (SIR) 0.80, confidence interval (CI) 95% 0.40-1.4]. An increased risk for lip cancer was found (SIR 23, CI 95% 2.8-85).
Conclusions: Confirmation of hypotheses about the mechanisms linking FXS and cancer needs further research.
Intersection of the fragile X-related disorders and the DNA damage response.
Kumari D, Grant-Bier J, Kadyrov F, Usdin K DNA Repair (Amst). 2024; 144:103785.
PMID: 39549538 PMC: 11789500. DOI: 10.1016/j.dnarep.2024.103785.
Cancer risks related to intellectual disabilities: A systematic review.
Banda A, Naaldenberg J, Timen A, van Eeghen A, Leusink G, Cuypers M Cancer Med. 2024; 13(9):e7210.
PMID: 38686623 PMC: 11058689. DOI: 10.1002/cam4.7210.
From Churchill to Elephants: The Role of Protective Genes against Cancer.
Gazzellone A, Sangiorgi E Genes (Basel). 2024; 15(1).
PMID: 38255007 PMC: 10815068. DOI: 10.3390/genes15010118.
A Double Jeopardy: Loss of FMRP Results in DSB and Down-regulated DNA Repair.
Chakraborty A, Grageda A, Kuznetsov V, Feng W 21 Century Pathol. 2023; 2(5).
PMID: 36688938 PMC: 9850805.
Cancer risk in individuals with intellectual disability in Sweden: A population-based cohort study.
Liu Q, Adami H, Reichenberg A, Kolevzon A, Fang F, Sandin S PLoS Med. 2021; 18(10):e1003840.
PMID: 34673770 PMC: 8568154. DOI: 10.1371/journal.pmed.1003840.